603233 Stock Overview
Manufactures, wholesales, and retails pharmaceutical products in China.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
DaShenLin Pharmaceutical Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.30 |
| 52 Week High | CN¥30.22 |
| 52 Week Low | CN¥14.28 |
| Beta | 0.20 |
| 11 Month Change | -29.31% |
| 3 Month Change | -32.99% |
| 1 Year Change | -48.95% |
| 33 Year Change | -59.37% |
| 5 Year Change | -39.05% |
| Change since IPO | 8.28% |
Recent News & Updates
Not Many Are Piling Into DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) Stock Yet As It Plummets 27%
Jun 17
Does DaShenLin Pharmaceutical Group (SHSE:603233) Have A Healthy Balance Sheet?
Jun 09Are Investors Undervaluing DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) By 30%?
May 21Recent updates
Not Many Are Piling Into DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) Stock Yet As It Plummets 27%
Jun 17Does DaShenLin Pharmaceutical Group (SHSE:603233) Have A Healthy Balance Sheet?
Jun 09Are Investors Undervaluing DaShenLin Pharmaceutical Group Co., Ltd. (SHSE:603233) By 30%?
May 21Some May Be Optimistic About DaShenLin Pharmaceutical Group's (SHSE:603233) Earnings
May 06Investors Could Be Concerned With DaShenLin Pharmaceutical Group's (SHSE:603233) Returns On Capital
Apr 09Lacklustre Performance Is Driving DaShenLin Pharmaceutical Group Co., Ltd.'s (SHSE:603233) Low P/E
Mar 17Shareholder Returns
| 603233 | CN Consumer Retailing | CN Market | |
|---|---|---|---|
| 7D | -7.2% | -5.3% | -2.2% |
| 1Y | -48.9% | -31.9% | -17.9% |
Return vs Industry: 603233 underperformed the CN Consumer Retailing industry which returned -31.2% over the past year.
Return vs Market: 603233 underperformed the CN Market which returned -17.4% over the past year.
Price Volatility
| 603233 volatility | |
|---|---|
| 603233 Average Weekly Movement | 5.3% |
| Consumer Retailing Industry Average Movement | 6.0% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in CN Market | 10.0% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 603233's share price has been volatile over the past 3 months.
Volatility Over Time: 603233's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 45,466 | Guoqiang Ke | www.dslyy.com |
DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China.
DaShenLin Pharmaceutical Group Co., Ltd. Fundamentals Summary
| 603233 fundamental statistics | |
|---|---|
| Market cap | CN¥16.29b |
| Earnings (TTM) | CN¥1.07b |
| Revenue (TTM) | CN¥25.34b |
15.2x
P/E Ratio0.6x
P/S RatioIs 603233 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603233 income statement (TTM) | |
|---|---|
| Revenue | CN¥25.34b |
| Cost of Revenue | CN¥16.47b |
| Gross Profit | CN¥8.86b |
| Other Expenses | CN¥7.79b |
| Earnings | CN¥1.07b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 31, 2024
| Earnings per share (EPS) | 0.94 |
| Gross Margin | 34.98% |
| Net Profit Margin | 4.22% |
| Debt/Equity Ratio | 45.3% |
How did 603233 perform over the long term?
See historical performance and comparison